Scythian Biosciences Progresses Towards Serving Argentina Medical Cannabis Market

0
41

TORONTO, April 09, 2018 (GLOBE NEWSWIRE) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and distribution company that Scythian is in the process of acquiring, has received its license to import CBD oil into Argentina (the “License”). ABP had previously entered into an exclusive international supply agreement for Argentina (the “Supply Agreement”) with Aphria Inc. (“Aphria”), a prominent Canadian producer of medical cannabis, in anticipation of receiving the License. Under the terms of the Supply Agreement, Aphria will supply ABP with cannabis products for research and development purposes as well as for distribution to hospitals, retail pharmacies, and private health providers in Argentina’s public health system. Scythian continues to raise the bar in the medical cannabis industry by joining forces with Aphria, a leading, world class cannabis cultivator and processor. Scythian Biosciences Progresses Towards Serving Argentina Medical Cannabis Market

thumbnail courtesy of newcannabisventures.com

Buy Marijuana Seeds

LEAVE A REPLY

Please enter your comment!
Please enter your name here